Rabobank Delft and SuperSeton (an NLC venture) signed a loan agreement securing growth financing for SuperSeton, a landmark achievement for both companies. This is a landmark for Rabobank, because it is exceptional for Rabobank to finance a healthtech startup which had not obtained CE yet. Furthermore, this is a landmark for SuperSeton, since this secures the introduction of the seton on the European market (once CE is obtained), which is expected in 2018. In the picture below, Ernst Elhorst (SuperSeton) and Anneke Olthuis (Rabobank).